MedPath

To know the action of Bilvadi Taila ear drops in comparison with Dipika Taila ear drops to use in Karnapoorana procedure in deafness.

Phase 3
Conditions
Health Condition 1: H907- Mixed conductive and sensorineuralhearing loss, unilateral with unrestricted hearing on the contralateral side
Registration Number
CTRI/2023/06/054345
Lead Sponsor
Dr Arshavikumari Chaudhari
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients attending OPD and IPD of Parul Ayurved Hospital.

2.Patients willing to enroll in clinical trial.

3.Patients aged between 21 to 60 years.

4.The subjective features of impaired hearing with associated symptoms tinnitus,vertigo,ear ache.

Deafness with intact eardrum.

5.Audiometery grading including Mild hearing loss from 26dB to 40dB and Moderate hearing loss from 41dB to 60dB.

Exclusion Criteria

1.Congenital sensorineural hearing loss.

2.Patients suffering from any chronic debilitating disease with other ear pathology and cases which required surgical intervention.

3.Perforated ear drum and Ear Discharge.

4.Immunocompromised patients.

5.Patient not willing to enroll in a clinical trial.

6.Audiometry grading including severe hearing loss from 61dB to 80dB and Profound hearing loss from 81dB or more.

7.Patients contraindicated for Karnapoorana Procedure.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement in Hearing CapacityTimepoint: Total 90 days <br/ ><br>0th day <br/ ><br>14th day <br/ ><br>28th day <br/ ><br>42nd day <br/ ><br>56th day <br/ ><br>70th day <br/ ><br>84th day <br/ ><br>90th day
Secondary Outcome Measures
NameTimeMethod
Improvement in Tinitus Vertigo EaracheTimepoint: Total 90 days <br/ ><br>0th day <br/ ><br>14th day <br/ ><br>28th day <br/ ><br>42nd day <br/ ><br>56th day <br/ ><br>70th day <br/ ><br>84th day <br/ ><br>90th day
© Copyright 2025. All Rights Reserved by MedPath